Acute myeloid leukaemia trials in China

In China 226 Also abroad 763

15 of 226 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Risk Stratification Value of Deep NGS-MRD Detection in Acute Myeloid Leukemia Patients After Allo-HSCT
Where
Tianjin
Age
18 years and over
People
169
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07919119
No phaseTaking people
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
Where
Hainan
Age
18 years to 75 years
People
30
Run by
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
See details and how to joinNCT07763054
No phaseNot yet taking people in China
Plasma ctDNA Monitoring in Pediatric Acute Leukemia
Where
Tianjin
Age
3 years to 18 years
People
25
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07751588
No phaseTaking people
Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
Where
Suzhou
Age
16 years and over
People
50
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07670130
No phaseTaking people
Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors
Where
Hangzhou
Age
8 years to 18 years
People
600
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07450872
No phaseTaking people
Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
Where
Beijing
Age
6 years to 60 years
People
210
Run by
Peking University People's Hospital
See details and how to joinNCT07537738
No phaseTaking people
The Efficacy of Allo-HSCT in ND HR-CBF-AML
Where
Shanghai
Age
18 years to 65 years
People
90
Run by
Ruijin Hospital
See details and how to joinNCT06458244
No phaseTaking people
Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML
Where
Beijing
People
100
Run by
Peking University People's Hospital
See details and how to joinNCT07500441
No phaseNot yet taking people in China
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
Where
Hangzhou, Ningbo
Age
1 year to 21 years
People
400
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07483749
No phaseTaking people
National Longitudinal Cohort of Hematological Diseases
Where
Tianjin
People
2,300
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199
No phaseTaking people
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
Where
Beijing
Age
Up to 18 years
People
283
Run by
Peking University People's Hospital
See details and how to joinNCT06452732
No phaseTaking people
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Where
Xining
People
1,000
Run by
Yigeng Cao,MD,PhD
See details and how to joinNCT07205523
No phaseTaking people
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Where
Shanghai
Age
18 years to 65 years
People
50
Run by
Ruijin Hospital
See details and how to joinNCT06458257
No phaseTaking people
Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
Where
Shanghai
Age
18 years to 55 years
People
50
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06111612
No phaseNot yet taking people in China
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
Where
Guanzhou
Age
14 years to 65 years
People
137
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT05875649